StockData
Johnson & Johnson logo

Johnson & Johnson (JNJ) stock

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3085% above fair value
$270.47+3.33 (+1.25%)

Close on Nov 20, 2026Market cap $651.11BP/E 41.0Yield 1.90%

Johnson & Johnson free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Johnson & Johnson's free cash flow for the twelve months ending Sep 27, 2026 was $20.59B, up 5.1% year over year. For fiscal 2025 it was $19.70B, down 0.7% from the year before. Over ten years it grew 2.0% a year on average. The highest annual figure on record is $20.19B in fiscal 2020.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 28, 2025$19.70B-0.7%
FY2024Dec 29, 2024$19.84B+8.7%
FY2023Dec 31, 2023$18.25B+6.2%
FY2022Jan 1, 2023$17.19B-13.0%
FY2021Jan 2, 2022$19.76B-2.1%
FY2020Jan 3, 2021$20.19B+1.4%
FY2019Dec 29, 2019$19.92B+7.5%
FY2018Dec 30, 2018$18.53B+4.2%
FY2017Dec 31, 2017$17.78B+14.4%
FY2016Jan 1, 2017$15.54B-3.5%
FY2015Jan 3, 2016$16.11B+7.4%
FY2014Dec 28, 2014$15.00B+8.5%
FY2013Dec 29, 2013$13.82B+10.9%
FY2012Dec 30, 2012$12.46B+9.3%
FY2011Jan 1, 2012$11.41B-18.5%
FY2010Jan 2, 2011$14.00B-1.4%
FY2009Jan 3, 2010$14.21B+19.3%
FY2008Dec 28, 2008$11.91B-1.4%
FY2007Dec 30, 2007$12.08B–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 27, 2026$6.36B-20.6%
Q2 FY2026Jun 28, 2026$7.30B+157.3%
Q1 FY2026Mar 29, 2026$1.47B-56.6%
Q4 FY2025Dec 28, 2025$5.47B+1.9%
Q3 FY2025Sep 28, 2025$8.01B+15.0%
Q2 FY2025Jun 29, 2025$2.84B-39.1%
Q1 FY2025Mar 30, 2025$3.38B+18.6%
Q4 FY2024Dec 29, 2024$5.37B-14.4%
Q3 FY2024Sep 29, 2024$6.96B+6.8%
Q2 FY2024Jun 30, 2024$4.66B+52.3%
Q1 FY2024Mar 31, 2024$2.85B+19.0%
Q4 FY2023Dec 31, 2023$6.27B+66.7%
Q3 FY2023Oct 1, 2023$6.52B+22.3%
Q2 FY2023Jul 2, 2023$3.06B-35.2%
Q1 FY2023Apr 2, 2023$2.39B-29.0%
Q4 FY2022Jan 1, 2023$3.76B-12.8%
Q3 FY2022Oct 2, 2022$5.33B-29.3%
Q2 FY2022Jul 3, 2022$4.72B+4.8%
Q1 FY2022Apr 3, 2022$3.37B-0.7%
Q4 FY2021Jan 2, 2022$4.32B-38.5%
Q3 FY2021Oct 3, 2021$7.54B-1.3%
Q2 FY2021Jul 4, 2021$4.50B+61.3%
Q1 FY2021Apr 4, 2021$3.40B+24.3%
Q4 FY2020Jan 3, 2021$7.02B+36.6%
Q3 FY2020Sep 27, 2020$7.65B+12.7%
Q2 FY2020Jun 28, 2020$2.79B-45.4%
Q1 FY2020Mar 29, 2020$2.73B-5.3%
Q4 FY2019Dec 29, 2019$5.14B+4.3%
Q3 FY2019Sep 29, 2019$6.78B+24.4%
Q2 FY2019Jun 30, 2019$5.11B-1.8%
Q1 FY2019Mar 31, 2019$2.89B-2.1%
Q4 FY2018Dec 30, 2018$4.93B+1.3%
Q3 FY2018Sep 30, 2018$5.45B-0.4%
Q2 FY2018Jul 1, 2018$5.20B+2.4%
Q1 FY2018Apr 1, 2018$2.95B+25.3%
Q4 FY2017Dec 31, 2017$4.87B-12.5%
Q3 FY2017Oct 1, 2017$5.48B–
Q2 FY2017Jul 2, 2017$5.08B–
Q1 FY2017Apr 2, 2017$2.35B–
Q4 FY2016Jan 1, 2017$5.56B–

More Johnson & Johnson figures

See a number that looks wrong?